Know About Taxotere Lawsuit
Taxotere is a chemotherapy drug prescribed for breast cancer treatment. It was approved by the Food and Drug Administration in 1996. Since then, taxotere has become the most popular drug used for treating breast cancer. Since then, it has become the most preferred drug prescribed to breast cancer patients. While the drug is effective in extending survival, one of its most glaring side effects is alopecia or permanent hair loss.
There are numerous chemotherapy drugs on the market, and Taxotere is not the only choice for doctors treating breast cancer patients. Unfortunately, Sanofi worked hard to steer doctors toward its product rather than less expensive drugs. Studies have found that Taxotere is actually less effective than cheaper competitors. In chemotherapy, a less effective drug means a lower survival rate. You can check out www.taxoterehairlawsuit.com/taxotere-lawsuit-lawyers.aspx to get more information regarding hair loss lawsuits.
Or if you were treated with Taxotere or any other form of docetaxel and your hair has not grown back, you may have a case for a lawsuit against Sanofi. Your lawsuit could result in a financial recovery that can help you pay for hospital bills, hair growth treatment, and the pain of losing your hair.
In the United States, women had no warning of permanent hair loss until 2015, when the FDA updated its safety information on Taxotere. The FDA added permanent hair loss warnings based on large numbers of reports from patients and doctors. Only after the FDA took this action did Sanofi update its own warnings to potential patients.
The symptoms of alopecia include:
- No eyebrows or eyelashes
- Complete lack of hair all over the body, including the legs